动脉僵硬与社区人群新发CKD及肾功能下降:ARIC研究
基于ARIC队列,纳入3161例基线无CKD的社区老年人,中位随访6.6年,460例发生CKD。cfPWV、hfPWV和haPWV最高四分位者新发CKD风险显著增加,且cfPWV、hfPWV、haPWV、baPWV和hcPWV较高与eGFR下降更快相关,faPWV无此关联。
要点
- cfPWV、hfPWV和haPWV最高四分位与新发CKD风险增加相关。
- cfPWV、hfPWV、haPWV、baPWV和hcPWV较高与eGFR下降更快相关。
- faPWV与新发CKD及eGFR斜率均无显著关联。
核心结论
- 较高的动脉僵硬(尤其是cfPWV、hfPWV和haPWV)与社区老年人新发CKD风险增加及eGFR更快下降前瞻性相关。
研究设计与样本
- 纵向队列研究,使用ARIC研究数据;主要分析纳入visit 5时无 prevalent CKD的3161名参与者,次要分析纳入visit 5至7有eGFR记录的4341名参与者。
主要发现
- 中位随访6.6年,460名参与者发生新发CKD,发病率为22.0/1000人年。
- 与Q1相比,cfPWV Q4的HR为1.53(95%CI 1.15-2.04),hfPWV Q4的HR为1.49(95%CI 1.12-1.99),haPWV Q4的HR为1.56(95%CI 1.16-2.08),均P<0.05。
- 次要分析中,与Q1相比,cfPWV Q4的eGFR斜率为-0.44 mL/min/1.73m2/年(95%CI -0.56至-0.33),Q1为-0.37(95%CI -0.48至-0.26),P<0.05;cfPWV、hfPWV、haPWV、baPWV和hcPWV的Q4均与更快的eGFR下降显著相关。
- faPWV与新发CKD或eGFR斜率无显著关联。
临床怎么用
- 在社区老年人中,可关注cfPWV、hfPWV和haPWV等动脉僵硬指标以识别CKD高风险个体,但需进一步研究验证干预价值。
局限性
- 存在残余混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Arterial stiffness is associated with prevalent chronic kidney disease (CKD). Whether arterial stiffness is prospectively associated with incident CKD is inconclusive. STUDY DESIGN: Longitudinal cohort study. SETTING & PARTICIPANTS: Using data from the Atherosclerosis Risk in Communities (ARIC) Study, the primary analysis included 3,161 participants without prevalent CKD at visit 5; a secondary analysis studied 4,341 participants with any estimated glomerular filtration rate (eGFR) record across visits 5 to 7. EXPOSURE: Carotid-femoral pulse wave velocity (cfPWV), heart-femoral PWV (hfPWV), heart-ankle PWV (haPWV), brachial-ankle PWV (baPWV), heart-carotid PWV (hcPWV), and femoral-ankle PWV (faPWV). OUTCOME: Primary analysis was incident CKD, defined as an eGFR<60mL/min/1.73m2 accompanied by>25% decline eGFR or CKD hospitalization. Secondary analysis was eGFR slope. ANALYTICAL APPROACH: For primary analysis, Cox regression models to calculate HR. For secondary analysis, multilevel mixed effects models to estimate the eGFR slope across visits. RESULTS: The median follow-up period was 6.6 years, in which 460 participants developed incident CKD (incidence rate 22.0 per 1,000 person-years). The highest quartiles (Q4) of cfPWV, hfPWV, and haPWV were associated with an increased risk of incident CKD compared with the lowest quartile (Q1) (HR, 1.53 [95% CI, 1.15-2.04]; HR, 1.49 [95% CI, 1.12-1.99], and HR, 1.56 [95% CI, 1.16-2.08], respectively) (P < 0.05). The results were consistent in subgroups. In the secondary analysis, the Q4s of cfPWV, hfPWV, haPWV, baPWV, and hcPWV were significantly associated with a faster eGFR decline compared to Q1 (eg, for cfPWV, -0.44mL/min/1.73m2/year [95% CI, -0.56 to-0.33] in Q4 vs-0.37 [95% CI, -0.48 to-0.26] in Q1) (P<0.05). faPWV was not associated with incident CKD or eGFR slope. LIMITATIONS: Residual confounding. CONCLUSIONS: Greater arterial stiffness, especially higher cfPWV, hfPWV, and haPWV, was prospectively associated with a higher risk of incident CKD and faster decline in eGFR among community-dwelling older adults, supporting a pathophysiological contribution of arterial stiffness to the development of CKD. PLAIN-LANGUAGE SUMMARY: Prior studies have shown a cross-sectional correlation between greater arterial stiffness and worse kidney function. We wanted to understand whether arterial stiffness is linked to the development of kidney disease. To explore this, we studied a group of adults over several years, measuring how stiff their arteries were using different pulse wave velocities from different sites. We found that people with stiffer arteries, particularly those with higher stiffness in specific areas like the carotid and femoral arteries, were more likely to develop chronic kidney disease. They also experienced a faster decline in kidney function. This suggests that artery stiffness may play a role in worsening kidney health over time. Our findings highlight the importance of managing artery stiffness to help prevent kidney disease in older adults.
引用
- Yao Z, Ishigami J, Kim E, et al. Arterial Stiffness and Subsequent Incidence of CKD and Kidney Function Decline in a Large Longitudinal Community Cohort: The Atherosclerosis in Communities (ARIC) Study. Am J Kidney Dis. 2025. PMID: 39863260. doi:10.1053/j.ajkd.2024.11.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。